The heterogeneity of tumour-associated macrophages contributes to the clinical outcomes and indications for immune checkpoint blockade in colorectal cancer patients
- Resource Type
- Article
- Source
- In
Immunobiology May 2024 229(3) - Subject
- Language
- ISSN
- 0171-2985